Brief: Lunit Meets Mdr CE Requirements For 3D Breast Tomosynthesis Ai Solution
March 20 (Reuters) - Lunit Inc 328130.KQ :
* LUNIT MEETS MDR CE REQUIREMENTS FOR 3D BREAST
TOMOSYNTHESIS AI
SOLUTION
* LUNIT INC - WITHIN Q3 OF THIS YEAR, LUNIT INTENDS TO START
PROCESS OF OBTAINING FDA APPROVAL FOR LUNIT INSIGHT DBT AS A
MEANS TO ENTER US MARKET
Source text for Eikon: ID:nPn5gHrDFa
Further company coverage: 328130.KQ
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lunit
See all newsBrief: Summit Therapeutics And Lunit Announce Agreement To Apply Ai-Powered Scope Io Platform For Tumor Microenvironment Analysis In Immuno-Oncology Development
Brief: Lunit Inc To Conduct Capital Increase Of 250 Billion Won
Brief: Lunit Announces Collaboration with Daiichi Sankyo on AI-Driven Biomarker Discovery
Brief: Lunit Inc - Awarded National Tender In France For Breast AI
Brief: Lunit Expands Partnership With Saudi Arabia's Largest Medical Group To Deploy Ai Chest X-Ray Solution